Treatment of advanced breast cancer with tamoxifen: Evaluation of the dose-response relationship at two dose levels
- 1 December 1982
- journal article
- scandinavian breast-cancer-symposium
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 2 (4), 395-400
- https://doi.org/10.1007/bf01805882
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.BMJ, 1981
- Clinical pharmacology of tamoxifen in patients with breast cancer: Correlation with clinical dataCancer, 1981
- Tamoxifen-induced remission in breast cancer by escalating the dose to 40 mg daily after progression on 20 mg daily: A case report and review of the literatureCancer, 1981
- Randomized Clinical Trial of Diethylstilbestrol versus Tamoxifen in Postmenopausal Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer InstituteEuropean Journal of Cancer (1965), 1980
- The binding of tamoxifen to human mammary carcinoma cytosolEuropean Journal of Cancer (1965), 1980
- Assessment of response to therapy in advanced breast cancerEuropean Journal of Cancer (1965), 1977
- Anti-Oestrogen Therapy of Advanced Mammary CarcinomaActa Radiologica: Therapy, Physics, Biology, 1976
- CONFIDENCE LIMITS IN EVALUATING CONTROLLED THERAPEUTIC TRIALSThe Lancet, 1973
- Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose LevelsBMJ, 1973